Renal functional measurements in young rats with chronic inhibition of nitric oxide synthase. 1996

H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
Department of Pediatrics, Fukui Medical School, Japan.

The purpose of the present study was to examine renal functional changes caused by chronic blockade of nitric oxide (NO) synthesis in young rats. Two types of NO synthase inhibitor were used: NG-nitro-L-arginine methyl ester (L-NAME) as a non-selective inhibitor and aminoguanidine (AG) as a selective inhibitor of the inducible isoform. Oral administration of L-NAME (20-80 mg/dL of drinking water), not AG (400 mg/dL), for 4 weeks induced systemic hypertension in the treated rats. Both inhibitors caused a significant reduction in urinary excretion of NO2-/NO3-. Rats treated with L-NAME developed proteinuria and tubular enzymuria (high excretion of N-acetyl-beta-D-glucosaminidase) in a dose-dependent fashion, with normal serum levels of creatinine, albumin and cholesterol. Chronic AG administration did not alter the urinary levels of protein and N-acetyl-beta-D-glucosaminidase or serum laboratory values. Overall, these observations highlight the importance of the continuous generation of NO by the constitutive isoform in the control of vascular tone and the maintenance of renal glomerular and tubular function. Oral administration of L-NAME may serve as a model of chronic NO-deficient hypertension with renal injury in young rats.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum

Related Publications

H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
February 2004, American journal of physiology. Renal physiology,
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
August 1995, Hypertension (Dallas, Tex. : 1979),
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
January 1998, Kidney & blood pressure research,
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
August 2018, Journal of the American Heart Association,
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
July 1995, Hypertension (Dallas, Tex. : 1979),
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
January 1995, Journal of the American Society of Nephrology : JASN,
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
June 2005, American journal of physiology. Endocrinology and metabolism,
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
July 2000, Clinical and experimental pharmacology & physiology,
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
November 1997, Hypertension (Dallas, Tex. : 1979),
H Tsukahara, and T Imura, and S Tsuchida, and M Nunose, and C Hori, and M Hiraoka, and F Gejyo, and M Sudo
September 1998, Kidney international. Supplement,
Copied contents to your clipboard!